Keep Health for Newsletter: Metformin's Major Issues

Preview text: Keep Health for Newsletter: Metformin's Major Issues 96 Is Metformin worth taking by…

Tuesday, Jul 7, 2026 at 1:36 PM EasternHubSpot

Keep HealthKeep Health for Newsletter: Metformin's Major Issues

Image not available

No image available for this email.

Subject: Keep Health for Newsletter: Metformin's Major Issues
Preview text: Keep Health for Newsletter: Metformin's Major Issues 96 Is Metformin worth taking by…
From: erik.sebesta@keep.health
Brand: Keep Health
ESP: HubSpot
Sent: Tue Jul 7, 2026, 1:36 PM ET
Size: 61 KB
Images: 3
Links: 26, 2 of them buttons
Subject length: 52 characters

Against Keep Health's usual

Sent in its busiest hour, 1 PM, which holds 27% of its emails. The subject is 52 characters; its average is 57.

Email headers

What the brand's servers put on this email. Our receiving servers, the address we subscribed with and unsubscribe links are left out.

From: Keep Health <[email protected]>
Reply-To: [email protected]
Subject: Keep Health for Newsletter: Metformin's Major Issues
Date: Tue, 7 Jul 2026 13:36:44 -0400
Message-ID domain: bf01.hubspotstarter.net
Return-Path domain: bf01.hubspotstarter.net
DKIM signature: d=bf01.hubspotstarter.net s=hs1; d=keep.health s=hs1-5289572
List-Unsubscribe: Present, one-click
Feedback-ID sender: HubSpot

from bid48j7.bf01.hubspotstarter.net [158.247.28.5] by our receiving server with ESMTPS

Other sending headers (names only): X-HS-Cid, X-Report-Abuse-To

	Aug 18, 2026 2:46 PM	Keep Health for Newsletter: Don't Vacillate to Vaccinate
	Jul 21, 2026 3:44 PM	Keep Health for Newsletter: Rejuvenation and Regeneration
	Jul 14, 2026 2:07 PM	Keep Health for Newsletter: Would you like a brain-computer interface?
	Jul 7, 2026 1:36 PM	Keep Health for Newsletter: Metformin's Major Issues (this email)
	Jun 23, 2026 2:59 PM	Keep Health for Newsletter: Mental Strength = + 3 Years
	Jun 2, 2026 11:41 AM	Keep Health for Newsletter: Nicotinamide Riboside Science 2026
	Mar 31, 2026 1:21 PM	Keep Health for Newsletter: Hyperbaric Oxygen Therapy